People: Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Nasdaq

3.88USD
22 Jul 2014
Price Change (% chg)

$0.05 (+1.31%)
Prev Close
$3.83
Open
$3.86
Day's High
$3.99
Day's Low
$3.82
Volume
678,739
Avg. Vol
1,169,231
52-wk High
$6.70
52-wk Low
$3.39

Search Stocks

Shailubhai, Kunwar 

Brief Biography

Dr. Kunwar Shailubhai is Chief Scientific Officer of Synergy Pharmaceuticals Inc., since July 2008. From March 2004 until July 2008 he served as Senior Vice President, Drug Discovery, of Synergy DE. From May 2003 until March 2004, Dr. Shailubhai served as Executive Vice President, Research and Development of Synergy DE. From 2001 to April 2003, Dr. Shailubhai held the position of Vice President, Drug Discovery at Synergy DE where he was chiefly responsible for the preclinical development of the GC-C agonist program for drugs to treat colon cancer and GI inflammation. Between 1993 and 2000, he was with Monsanto Company, serving as Group Leader of the cancer chemoprevention group. Dr. Shailubhai previously served as a Senior Staff Fellow at the National Institutes of Health, and as an Assistant Professor at the University of Maryland. Dr. Shailubhai received his Ph.D. in microbiology in 1984 from the University of Baroda, India, and his M.B.A. in 2001 from the University of Missouri, St. Louis.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
368,500 -- 300,671 669,171

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gabriele Cerrone

739,911

Gary Jacob

920,536

Bernard Denoyer

460,302

Paul Eng

--

Marino Garcia

--

Kunwar Shailubhai

669,171
As Of 30 Dec 2013
Search Stocks